Cambridge Healthtech Institute’s 13th Annual

Liquid Biopsy

Enabling Precision Oncology for Diagnostic and Drug Development

March 6-7, 2023


Liquid biopsy is a maturing technology for early detection of disease, patient stratification and therapy selection, monitoring response to therapy, and detecting disease recurrence. Cambridge Healthtech Institute’s 13th Annual Liquid Biopsy meeting will explore the latest technologies in detection and molecular characterization of CTCs, cell-free circulating tumor DNA (cfDNA) and circulating extracellular RNA, exosomes and microvesicles, as well as the applications of liquid biopsy in diagnostics and drug development.


Coverage will include, but is not limited to:


  • Technology update in liquid biopsy detection and characterization
  • Cancer screening and early detection
  • Liquid biopsy for minimal residual disease detection
  • Applications of cell-free DNA and RNA as biomarkers in drug development
  • Exosomes and microvesicles as biomarkers
  • Predicting immunotherapy response through circulating immune cells
  • Liquid biopsy for companion diagnostics


The deadline for priority consideration is July 29, 2022.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


Opportunities for Participation:



For more details on the conference, please contact:

Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute



For sponsorship information, please contact:

Jon Stroup

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5483


Register Now

Conference Programs

March 6-7, 2023

Implementing Precision Medicine

Digital Medicine

At-Home & Point-of-Care Diagnostics

Liquid Biopsy

Spatial Biology

March 7-8, 2023

Precision Health

Diagnostics Innovation and Market Access

Infectious Disease Diagnostics

Advanced Diagnostics for Precision Oncology

Single-Cell Multiomics